Tolerance to chemotherapy in elderly patients with cancer.
about
Multiple myeloma in the very elderly patient: challenges and solutionsOlder breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up.The impact of low-grade toxicity in older people with cancer undergoing chemotherapyAge-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levelsHow does older age influence oncologists' cancer management?The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people.Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.Senior adult oncology.Older adults and cancer treatment.Colorectal cancer treatment and follow-up in the elderly: an inexplicably different approachGlutathione maintenance mitigates age-related susceptibility to redox cycling agents.Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.Could Adjuvant Chemotherapy after Surgery Benefit Elderly Patients with Advanced Gastric Cancer?Chemotherapy options in elderly and frail patients with metastatic colorectal cancer.Aging, nutrient signaling, hematopoietic senescence, and cancer.Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung CancerInduction Chemotherapy plus Concurrent Chemoradiotherapy vs Concurrent Chemoradiotherapy in Elderly Patients with Advanced Nasopharyngeal Carcinoma.Multiple myeloma in the very old: an IASIA conference report.Changes in the use of end points in clinical trials for elderly cancer patients over time.Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy.Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme
P2860
Q26752991-B36AA3F6-388D-4A37-B336-6E42B3326037Q33627703-DE71E106-015C-4AAB-BC32-B49350F9AA45Q34686967-1EB7210E-D134-4FD3-9E66-95757AEB3727Q34712254-B65A346F-6232-4781-9C16-9EA73E0EFF5AQ35584140-95079874-2D1A-499C-AF27-FDA55D75484DQ35677917-2D8D6E00-FD18-433F-B29D-9C06C36193EBQ36117722-C5594609-F65C-475C-8CC8-666FF8D3C8FEQ36851424-CBF1A12B-5250-4151-AAFF-A6A3156E479DQ37023167-34959D05-3A26-41D3-9E3B-89BD60E88532Q37044927-17E84D0A-28F8-4C56-98D1-9E90A3C935B6Q37293046-E2013382-AC17-4AE4-A04D-4DBEEFAA432DQ37474079-53E5A0BB-7BC8-40A4-AF4C-CCAD0E416EE7Q37549221-F1AB9015-E8B2-4139-88A8-02E17147D842Q37647279-1D8C5C89-2488-4DD3-BFE0-A951563061D1Q38191999-12908482-07F2-4409-8986-01F5843B8F0AQ38938753-E94CA34B-35EA-49BC-8FBF-E903D87DD4FFQ40238608-211B235C-B89F-40FE-97A0-D89D7A71472CQ43242121-FEAB23D9-F89D-461D-BCB0-3F5502E37E16Q48582976-C5C8E798-F91D-4394-93DF-BBF5E791901CQ51815957-9A34044D-AC34-4E6B-BE49-DEB748700A13Q58721237-34E115C2-B7ED-4D58-A4B8-E26B2552C6C8
P2860
Tolerance to chemotherapy in elderly patients with cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tolerance to chemotherapy in elderly patients with cancer.
@ast
Tolerance to chemotherapy in elderly patients with cancer.
@en
type
label
Tolerance to chemotherapy in elderly patients with cancer.
@ast
Tolerance to chemotherapy in elderly patients with cancer.
@en
prefLabel
Tolerance to chemotherapy in elderly patients with cancer.
@ast
Tolerance to chemotherapy in elderly patients with cancer.
@en
P2093
P2860
P1433
P1476
Tolerance to chemotherapy in elderly patients with cancer.
@en
P2093
Carsten Bokemeyer
Friedemann Honecker
Klaus Höffken
Ludger Pientka
Ulrich Wedding
P2860
P356
10.1177/107327480701400106
P577
2007-01-01T00:00:00Z